Beijing Hotgen Biotech Co Ltd688068
▲ PositiveCapitalrelevance
Company completed a 50.02 million yuan share buyback, signaling confidence.

Hotgen Biotech announced that as of July 31, 2026, it had repurchased 580,000 shares, accounting for 0.63% of total share capital, with a total repurchase amount of 50.02 million yuan and a repurchase price range of 79.25 yuan to 91.06 yuan per share. In the first quarter of 2026, the company achieved revenue of 116 million yuan and a net loss attributable to the parent company of 68.06 million yuan.
Beijing Hotgen Biotech Co LtdCompany completed a 50.02 million yuan share buyback, signaling confidence.